XML 18 R7.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock Voting
Additional Paid In Capital
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Retained Earnings
Beginning balance (in shares) at Mar. 31, 2019   119,760,132     42,149,771  
Beginning balance at Mar. 31, 2019 $ 2,065,433 $ 120 $ 2,828,922 $ (2,639) $ (1,119,063) $ 358,093
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (10,090)         (10,090)
Unrealized net investment gains (losses) 40     40    
Unrealized net gains on derivative financial instruments 43     43    
Cumulative translation adjustments (789)     (789)    
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   1,621,350        
Issuance of common stock pursuant to vesting of restricted stock units 2 $ 2        
Stock-based compensation expense for restricted stock units granted to employees 38,187   38,187      
Issuance of common stock under employee stock purchase plan (in shares)   297,635        
Issuance of common stock under employee stock purchase plan 6,593   6,593      
Repurchase of treasury stock (in shares)         5,674,125  
Repurchase of treasury stock (136,612)       $ (136,612)  
Ending balance (in shares) at Dec. 31, 2019   121,679,117     47,823,896  
Ending balance at Dec. 31, 2019 1,962,807 $ 122 2,873,702 (3,345) $ (1,255,675) 348,003
Beginning balance (in shares) at Sep. 30, 2019   121,648,747     46,810,700  
Beginning balance at Sep. 30, 2019 1,940,264 $ 122 2,863,003 (3,699) $ (1,230,440) 311,278
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 36,725         36,725
Unrealized net investment gains (losses) 3     3    
Unrealized net gains on derivative financial instruments 54     54    
Cumulative translation adjustments 297     297    
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   30,370        
Issuance of common stock pursuant to vesting of restricted stock units 0          
Stock-based compensation expense for restricted stock units granted to employees 10,699   10,699      
Repurchase of treasury stock (in shares)         1,013,196  
Repurchase of treasury stock (25,235)       $ (25,235)  
Ending balance (in shares) at Dec. 31, 2019   121,679,117     47,823,896  
Ending balance at Dec. 31, 2019 1,962,807 $ 122 2,873,702 (3,345) $ (1,255,675) 348,003
Beginning balance (in shares) at Mar. 31, 2020   122,006,077     49,785,171  
Beginning balance at Mar. 31, 2020 1,937,919 $ 122 2,891,553 (3,160) $ (1,305,935) 355,339
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 7,915         7,915
Unrealized net investment gains (losses) (122)     (122)    
Unrealized net gains on derivative financial instruments 169     169    
Cumulative translation adjustments 3,375     3,375    
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   1,581,484        
Issuance of common stock pursuant to vesting of restricted stock units 2 $ 2        
Stock-based compensation expense for restricted stock units granted to employees 38,545   38,545      
Issuance of common stock under employee stock purchase plan (in shares)   279,812        
Issuance of common stock under employee stock purchase plan 6,475   6,475      
Repurchase of treasury stock (in shares)         644,178  
Repurchase of treasury stock (16,043)       $ (16,043)  
Ending balance (in shares) at Dec. 31, 2020   123,867,373     50,429,349  
Ending balance at Dec. 31, 2020 1,978,235 $ 124 2,936,573 262 $ (1,321,978) 363,254
Beginning balance (in shares) at Sep. 30, 2020   123,840,945     50,266,910  
Beginning balance at Sep. 30, 2020 1,939,320 $ 123 2,924,757 (1,258) $ (1,318,535) 334,233
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 29,021         29,021
Unrealized net investment gains (losses) (15)     (15)    
Unrealized net gains on derivative financial instruments 53     53    
Cumulative translation adjustments 1,482     1,482    
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   26,428        
Issuance of common stock pursuant to vesting of restricted stock units 1 $ 1        
Stock-based compensation expense for restricted stock units granted to employees 11,816   11,816      
Repurchase of treasury stock (in shares)         162,439  
Repurchase of treasury stock (3,443)       $ (3,443)  
Ending balance (in shares) at Dec. 31, 2020   123,867,373     50,429,349  
Ending balance at Dec. 31, 2020 $ 1,978,235 $ 124 $ 2,936,573 $ 262 $ (1,321,978) $ 363,254